From: In vitro gentamicin exposure alters caveolae protein profile in cochlear spiral ligament pericytes
A Biological process | |||
GO term | Description | FDR q-value | Enrichment (N, B, n, b) |
GO:0090304 | nucleic acid metabolic process | 2.59E-10 | 1.96 (2597,537,249,101) |
GO:0016070 | RNA metabolic process | 3.1E-10 | 2.06 (2597,455,249,90) |
GO:0006139 | nucleobase-containing compound metabolic process | 1.86E-5 | 1.61 (2597,673,249,104) |
GO:0046483 | heterocycle metabolic process | 4.34E-5 | 1.57 (2597,704,249,106) |
GO:0006725 | cellular aromatic compound metabolic process | 6.41E-5 | 1.56 (2597,694,249,104) |
GO:0006351 | transcription, DNA-templated | 7.04E-5 | 2.23 (2597,210,249,45) |
GO:0097659 | nucleic acid-templated transcription | 6.03E-5 | 2.23 (2597,210,249,45) |
GO:0010468 | regulation of gene expression | 7.14E-5 | 1.66 (2597,539,249,86) |
GO:0032774 | RNA biosynthetic process | 8.61E-5 | 2.19 (2597,214,249,45) |
GO:0006396 | RNA processing | 9.71E-5 | 2.13 (2597,230,249,47) |
B Cellular component | |||
GO term | Description | FDR q-value | Enrichment (N, B, n, b) |
GO:0044428 | nuclear part | 1.15E-6 | 1.54 (2597,855,249,126) |
GO:0005634 | nucleus | 4.66E-6 | 1.38 (2597,1160,249,154) |
C Molecular function | |||
GO term | Description | FDR q-value | Enrichment (N, B, n, b) |
GO:0003676 | nucleic acid binding | 5.68E-10 | 1.70 (2597,779,249,127) |
GO:0003677 | DNA binding | 1.58E-7 | 2.36 (2597,243,249,55) |
GO:0000975 | regulatory region DNA binding | 8.02E-7 | 3.56 (2597,79,249,27) |
GO:0044212 | transcription regulatory region DNA binding | 6.01E-7 | 3.56 (2597,79,249,27) |
GO:0001067 | regulatory region nucleic acid binding | 9.13E-7 | 3.48 (2597,81,249,27) |
GO:0043565 | sequence-specific DNA binding | 1.34E-5 | 3.09 (2597,91,249,27) |
GO:1990837 | sequence-specific double-stranded DNA binding | 4.73E-5 | 3.48 (2597,63,249,21) |